Topiramate Tablet, Film Coated
Product Images NDC 80425-0495

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure diagram of the active ingredient topiramate, showing its molecular arrangement with various carbon, oxygen, sulfur, nitrogen, and hydrogen atoms connected by bonds.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A line graph showing cumulative rates for time to first seizure over a 500-day period comparing topiramate 50 mg/day and 400 mg/day dosages. The x-axis represents time in days, and the y-axis shows cumulative rates. The graph includes a p-value of 0.0002 indicating statistical significance between the groups.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and topiramate at 50 mg/day, 100 mg/day, and 200 mg/day doses across two studies labeled Study 1 and Study 2. The vertical axis represents the change in migraine rate, while the horizontal axis shows treatment groups with number of subjects noted. Statistical significance indicators for the topiramate groups are included below the chart.*
FDA Label Image

Topiramate 50mg #30 (Topiramate 50mg 80425 0495 01)

Topiramate 50mg #30 (Topiramate 50mg 80425 0495 01)
Topiramate 50 mg film-coated tablet packaging label from Advanced Rx of Tennessee, LLC. The label includes storage instructions to keep the product at 20°-25°C (68°-77°F). It indicates a package count of 30 tablets and states the product is for prescription use only. The label also references comparison to Topamax and includes lot and expiration date information.*
FDA Label Image

Topiramate 50mg #60 (Topiramate 50mg 80425 0495 02)

Topiramate 50mg #60 (Topiramate 50mg 80425 0495 02)
Label for topiramate 50 mg film-coated tablets by Advanced Rx of Tennessee, LLC. It includes storage instructions (20-25°C), a barcode, lot number and expiration date placeholders, and caution about federal transfer laws. The label references Topamax and shows the product NDC 80425-0495-02 and a medication count of 60 tablets.*
FDA Label Image

Topiramate 50mg #90 (Topiramate 50mg 80425 0495 03)

Topiramate 50mg #90 (Topiramate 50mg 80425 0495 03)
Topiramate 50 mg film-coated tablet label from Advanced Rx of Tennessee, LLC, with a note to compare to Topamax. It includes storage instructions at 20°-25°C (68°-77°F), prescription-only status, lot number, expiration date, and barcodes. The label shows the NDC 80425-0495 and manufacturer information from Unichem Pharmac.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.